STAR EQUITY HOLDINGS INC (STRR)
US85513Q1031 - Common Stock
STRR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 118 industry peers in the Health Care Providers & Services industry. While STRR has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, STRR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year STRR has reported negative net income.
STRR had a positive operating cash flow in the past year.
STRR had negative earnings in 4 of the past 5 years.
In multiple years STRR reported negative operating cash flow during the last 5 years.
1.2 Ratios
STRR has a Return On Assets of 30.76%. This is amongst the best in the industry. STRR outperforms 99.15% of its industry peers.
With an excellent Return On Equity value of 35.56%, STRR belongs to the best of the industry, outperforming 95.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.76% | ||
| ROE | 35.56% | ||
| ROIC | N/A |
ROA(3y)4.58%
ROA(5y)-0.3%
ROE(3y)1.53%
ROE(5y)-5.85%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of STRR (50.71%) is better than 97.44% of its industry peers.
STRR's Profit Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 26.04%, STRR is in line with its industry, outperforming 51.28% of the companies in the same industry.
In the last couple of years the Gross Margin of STRR has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 50.71% | ||
| GM | 26.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y137.45%
GM growth 3Y13.31%
GM growth 5Y8.2%
2. Health
2.1 Basic Checks
STRR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, STRR has more shares outstanding
The number of shares outstanding for STRR has been increased compared to 5 years ago.
STRR has a better debt/assets ratio than last year.
2.2 Solvency
STRR has an Altman-Z score of -0.32. This is a bad value and indicates that STRR is not financially healthy and even has some risk of bankruptcy.
STRR's Altman-Z score of -0.32 is on the low side compared to the rest of the industry. STRR is outperformed by 65.81% of its industry peers.
STRR has a debt to FCF ratio of 3.40. This is a good value and a sign of high solvency as STRR would need 3.40 years to pay back of all of its debts.
STRR's Debt to FCF ratio of 3.40 is amongst the best of the industry. STRR outperforms 81.20% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that STRR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, STRR belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 3.4 | ||
| Altman-Z | -0.32 |
ROIC/WACCN/A
WACC7.02%
2.3 Liquidity
STRR has a Current Ratio of 3.99. This indicates that STRR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of STRR (3.99) is better than 90.60% of its industry peers.
STRR has a Quick Ratio of 3.59. This indicates that STRR is financially healthy and has no problem in meeting its short term obligations.
STRR has a Quick ratio of 3.59. This is amongst the best in the industry. STRR outperforms 90.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.99 | ||
| Quick Ratio | 3.59 |
3. Growth
3.1 Past
The earnings per share for STRR have decreased strongly by -235.29% in the last year.
STRR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.43% yearly.
The Revenue for STRR has decreased by -46.20% in the past year. This is quite bad
The Revenue for STRR have been decreasing by -15.17% on average. This is quite bad
EPS 1Y (TTM)-235.29%
EPS 3YN/A
EPS 5Y33.43%
EPS growth Q2Q-121.43%
Revenue 1Y (TTM)-46.2%
Revenue growth 3Y-16.34%
Revenue growth 5Y-15.17%
Revenue growth Q2Q-56.1%
3.2 Future
Based on estimates for the next years, STRR will show a very strong growth in Earnings Per Share. The EPS will grow by 34.69% on average per year.
The Revenue is expected to grow by 15.51% on average over the next years. This is quite good.
EPS Next Y4.65%
EPS Next 2Y35.82%
EPS Next 3Y34.69%
EPS Next 5YN/A
Revenue Next Year8.49%
Revenue Next 2Y15.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
STRR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year STRR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
70.94% of the companies in the same industry are more expensive than STRR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.56 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as STRR's earnings are expected to grow with 34.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.82%
EPS Next 3Y34.69%
5. Dividend
5.1 Amount
No dividends for STRR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
STAR EQUITY HOLDINGS INC
NASDAQ:STRR (5/6/2024, 7:00:00 PM)
0.92
+0.02 (+2.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap14.58M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.76% | ||
| ROE | 35.56% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | 50.71% | ||
| GM | 26.04% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.99 | ||
| Quick Ratio | 3.59 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-235.29%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y4.65%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-46.2%
Revenue growth 3Y-16.34%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y